Lv1
60 积分 2025-03-10 加入
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases
5小时前
已完结
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study
1天前
已完结
A real-world pharmacovigilance study of QT interval prolongation and Torsades de Pointes associated with CDK4/6 inhibitors in breast cancer patients: findings from the FDA adverse event reporting system
2天前
已完结
Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis
2个月前
已完结
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
2个月前
已完结
An overview of scientometric mapping for the safety science community: Methods, tools, and framework
3个月前
已完结
Scientometric analysis and knowledge mapping of literature-based discovery (1986-2020)
3个月前
已完结
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial
3个月前
已关闭
皖公网安备34019202002308
